Investor Relations Home

2014 Annual Report
2014 Annual Report
2012 Annual Report
2012 Annual Report
2011 Annual Report
2011 Annual Report
2009 Annual Report
2009 Annual Report
2008 Annual Report
2008 Annual Report
2007 Annual Report
2007 Annual Report
Stock Quote
MASI (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Change (%) Stock is Up 0.95 (1.49%)
Data as of 12/09/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Online Investor Kit
Masimo Reports Third Quarter 2016 Financial Results
2015 Form 10K
2016 Proxy Statement
2014 Annual Report
Corporate Profile
We are a global medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. We were incorporated in California in May 1989 and reincorporated in Delaware in May 1996.

Our core business is measure through motion and low perfusion arterial blood oxygen saturation and pulse rate monitoring, kno... 
More >>
Upcoming EventsMore >>
There are currently no events scheduled.
Recent News
| More >>
Masimo to Present at 28th Annual Piper Jaffray Healthcare Conference - 11/22/16
IRVINE, Calif.--(BUSINESS WIRE)--Nov. 22, 2016-- Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the 28th Annual Piper Jaffray Healthcare Conference at the New York Palace on Tuesday, N... More >>
Masimo Receives Gates Foundation Grant to Develop Combined Pneumonia-Screening Device for High-Burden Settings - 11/11/16
IRVINE, Calif.--(BUSINESS WIRE)--Nov. 11, 2016-- Masimo (NASDAQ: MASI) announced today, in advance of World Pneumonia Day tomorrow, that it has received a grant of $4.95 million from the Bill & Melinda Gates Foundation... More >>
Philips and Masimo Sign Multi-Year Business Partnership Agreement in Patient Monitoring and Select Therapy Solutions - 11/07/16
Multi-year business partnership combines Masimo’s expertise in non-invasive sensor and signal processing technologies and Philips’ expertise in integrated patient monitoring and therapy solutions Business pa... More >>
Masimo Reports Third Quarter 2016 Financial Results - 11/02/16
Q3 2016 Highlights (compared to Q3 2015): Total revenue, including royalties, rose 9.9% to $167.6 million Product revenue rose 10.8% to $160.3 million Masimo rainbow® revenue ... More >>
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Masimo Corporation posts new information to the site. Just enter your e-mail address and click Submit.

To request a copy of the Annual Report, click here.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.